On May 18, 2022, Shenzhen stock exchange sent an inquiry letter to Shenzhen Glory Medical Co.Ltd(002551) (SZ Shenzhen Glory Medical Co.Ltd(002551) , closing price: 4.53 yuan): for “Your 2021 annual financial accounting report was issued with a qualified opinion by the annual audit accountant. The qualified opinion involves one of the matters. First, Qinhuangdao Guangji Hospital Management Co., Ltd., which is invested by your company’s wholly-owned subsidiary, Shenzhen Shenzhen Glory Medical Co.Ltd(002551) Investment Co., Ltd., entered the liquidation on August 2, 2021. As of the end of the reporting period, the total investment cost was 182 million yuan, with a cumulative impairment of 215801 million yuan. As the liquidation plan has not been determined, the annual audit accountant has no The method obtains sufficient and appropriate audit evidence for the rationality of impairment provision of this investment in 2020 and 2021. ” The Shenzhen Stock Exchange proposed, including “explaining the establishment time of Guangji medical management, the paid in capital contribution time and amount of Shangrong investment in each period, and whether Shangrong investment performs its capital contribution obligations as agreed and the reasons and basis for the court’s judgment on the dissolution of Guangji medical management.” And other requirements.
From January to December of 2021, Shenzhen Glory Medical Co.Ltd(002551) the operating revenue is composed of 63.14% of medical products, 33.13% of hospital logistics custody services and 3.73% of others.
